USA: (+1) 929-659-6832 |  EU: (+44) 73-0721-4177
info@cognitivemarketresearch.com
D&B D-U-N-S No : 85-356-3074
Segment · Pharma and Healthcare

Biosimilars Industry Analysis and Consulting Services

Market sizing, forecasts, competitive intelligence and custom consulting for the Biosimilars industry — backed by primary research with industry experts.

Talk to an Analyst Browse Reports
IndustryAll reports
Banking and Finance Agriculture Aerospace and Defense Automotive and Automobile Transportation and Logistics Consumer Chemical and Materials Energy and Power Food and Beverages Electronics and Electricals Internet and Communication Machinery and Equipment Manufacturing and Construction Medical Devices and Consumables Pharma and Healthcare Service and Software
No match
Same level↑ Biologics and Biosimilars
Monoclonal Antibodies Recombinant Proteins Biosimilars
No match
Region
Global North America Market Europe Market Asia Pacific Market South America Market Middle East Market Africa Market
Showing 13–24 of 51 reports

Biosimilars Industry Overview

Cognitive Market Research tracks the Biosimilars industry as part of the Biologics and Biosimilars sector, covering market size, share, growth forecasts, pricing, regional demand and the competitive landscape. Our analysts combine primary interviews with industry experts and secondary research to help companies size opportunities, benchmark competitors and plan entry and expansion strategies.

List of Biosimilars Industry Reports

Biosimilars Industry Statistics & Data Insights

Product / IndustryUnit 2021Base year2025Current2033ForecastCAGRGrowth rate
Biosimilars Market Million
12,627
23,964
86,313
 17.372%
Interferon Alpha-2a Biosimilar Sales Market Million
540
790
1,694
 10%
Interferon Biosimilar Market Million
2,336
3,435
7,428
 10.12%
Interferon Alpha 2b Biosimilar Market Million
915
1,054
1,399
 3.6%
Adalimumab Biosimilar Market Million
380
779
3,504
 20.67%
Infliximab and biosimilar Market Million
6,286
8,721
16,789
 8.531%
Infliximab Biosimilar Market Million
2,006
3,218
8,281
 12.539%
Trastuzumab Biosimilar Market Million
2,213
3,898
12,091
 15.2%
Bevacizumab Biosimilar Market Million
1,573
3,818
24,439
 26.12%
Generic and Biosimilar Pharmaceuticals Market Billion
314
418
745
 7.473%
≥10% High growth5–9% Mid<5% Low

Biosimilars Sub-Industry Athenaeum

Athenaeum gives you on-demand access to market data, forecasts and company intelligence across every Biosimilars segment — in one searchable research library.

Monoclonal AntibodiesRecombinant Proteins
Explore Athenaeum